Lecithin – a natural fibrate?

cholesterol

cholesterol

In medicine, fibrates are drugs used to help reduce high cholesterol. They do this via activation of the alpha subtype of the Peroxisome Proliferator-Activated Receptor, or PPAR?. The PPARs are a family of proteins that play an essential role in metabolism. There are three subtypes in the family – alpha, beta (also known as delta due to initial confusion by scientists who erroneously thought they were two distinct receptors) and gamma – although gamma has three sub-forms itself; gamma-1, gamma-2 and gamma-3. These receptors are expressed throughout the body, with varying different effects upon activation. However it is PPAR? that were are interested in for this article.

Very basically, activating PPAR? is generally associated with increased fat burning, increased high density lipoprotein (the “good” cholesterol), and increased lipoprotein lipase (LPL) activity, which helps reducing low density lipoprotein (the “bad” cholesterol).These effects seem to help control blood sugar also, possibly by reducing insulin resistance. This makes PPAR? very appealing as a target for anti-obesity, anti-diabetic and anti-hyperlipidemia drugs. So much so, that exciting research coming out of the Washington University School of Medicine has identified a natural ligand called 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (POPC). What is truly exciting is that this is a constituent of the naturally occurring group of phospholipids and fatty acids known as lecithin. Lecithin is found in eggs and soy beans, and is used regularly as a food additive, most notably in chocolate where it improves the texture. The researchers found that POPC was a good PPAR? in the liver, and had some very weak activity on the PPAR-beta receptor. Lecithin is not 100% POPC, but adding it to your diet may be of benefit as POPC is a derivative of phophatidylcholine, which is one of the main constituents of lecithin.

Source: Chakravarthy MV, Lodhi IJ, Yin L, Malapaka RR, Xu HE, Turk J, Semenkovich CF. Identification of a Physiologically Relevant Endogenous Ligand for PPARalpha in Liver. Cell. 2009 Jul 29.

About the Author

Matt Cahill has worked extensively in the nutritional supplement field, and is the former CEO of Designer Supplements. During his time in the field has researched and developed prohormones, testosterone boosters, and other related compounds, both for his own company and others.